共 151 条
[1]
Blower PR(1990)The role of specific 5-HT3 receptor antagonism in the control of cytostatic drug-induced emesis Eur J Cancer 26 S8-S11
[2]
De Mulder PH(1990)Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study Ann Intern Med 113 834-840
[3]
Seynaeve C(2003)Delayed chemotherapy-induced nausea in women treated for breast cancer Oncol Nurs Forum 30 E40-E47
[4]
Vermorken JB(1991)Progress in the control of acute and delayed emesis induced by cisplatin Eur J Cancer 27 9-11
[5]
van Liessum PA(1992)The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo Semin Oncol 19 67-71
[6]
Mols-Jevdevic S(2000)Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology J Clin Oncol 17 2971-2994
[7]
Allman EL(1996)On the receiving end. V. Patient perceptions of the side effects of cancer chemotherapy in 1993 Ann Oncol 7 189-195
[8]
Beranek P(2004)Incidence of chemotherapy-induced nausea and emesis after modern antiemetics Cancer 100 2261-2268
[9]
Verweij J(1996)A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesis Cancer Chemother Pharmacol 38 323-328
[10]
Dibble SL(1994)A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis J Clin Oncol 12 596-600